Panelists discuss how current multiple sclerosis (MS) therapies show limited effectiveness against progression, but emerging ...

Panelists discuss how chronic neuroinflammation involves distinct mechanisms from acute relapses—including microglial ...

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

No writing assistance was utilized in the production of this drug profile manuscript. Cite this: FTY720 (Fingolimod) for Relapsing Multiple Sclerosis - Medscape - May 01, 2008.

Top 10 Needs of People With Multiple Sclerosis and Their Significant Others Wilma J. Koopman; Cathy-Lee Benbow; Margaret Vandervoort Disclosures J Neurosci Nurs. 2006;38 (5):369-373. 0 ...

Source Reference: Vitkova M, et al "Association of latitude and exposure to ultraviolet B radiation with severity of multiple sclerosis: an international registry study" Neurology 2022; DOI: 10. ...

Although no specific pain scale has demonstrated its superiority as a reliable biomarker and gold standard yet, 4 it is noteworthy that, for some authors, the use of multidimensional scales in ...

Patient pain can be detected highly reliably from facial expressions using a set of facial muscle-based action units (AUs) defined by the Facial Action Coding System (FACS). A key characteristic of ...